A review of antithrombotic treatment trials in atrial fibrillation discusses risk stratification and presents recommendations for anticoagulation to prevent stroke.
What are the recommendations for antithrombotic treatment and risk stratification in patients with atrial fibrillation?
This review discusses evidence from antithrombotic treatment trials, risk stratification, and recommendations for anticoagulation in patients with atrial fibrillation.
Atrial fibrillation (AF) can significantly increase morbidity and mortality. It is gaining in clinical and economic importance, being the most commonly encountered tachyarrhythmia in clinical practice. Stroke is the most serious complication. Evidence from AF antithrombotic treatment trials is reviewed, risk stratification of patients with AF is discussed, and recommendations for anticoagulation are presented.
Lip et al. (Wed,) conducted a review in Atrial fibrillation. Antithrombotic treatment was evaluated. A review of antithrombotic treatment trials in atrial fibrillation discusses risk stratification and presents recommendations for anticoagulation to prevent stroke.